Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1]. |
In vitro | Anticancer agent 74 exhibits low cytotoxicity in HepG2 (IC 50 : 72.27 μM), A549 (IC 50 : 70.79 μM), HuCCA-1 (IC 50 : 70.42 μM), and MOLT-3 (IC 50 : 20.71 μM) cell lines, alongside low selectivity with IC 50 values of 0.88 μM for HepG2, 5.08 μM for A549, 5.11 μM for HuCCA-1, and 17.39 μM for MOLT-3, respectively [1]. Despite its good cytotoxic effects, the compound demonstrates low selectivity across these primary cancer cell types, as assessed in cytotoxicity assays involving the A549, HuCCA-1, HepG2, and MOLT-3 cell lines. |
Molecular Weight | 351.44 |
Formula | C25H21NO |
Cas No. | 2242503-82-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.